Departure. Clinical Miss. Billion: Should You Bet on Pfizer?
Pfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Identify the credit cards that offer rewards without annual fees. Enjoy benefits without the financial strain.
27,064 articlesPfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Paradigm just closed a $1.2B fund, signaling a bold move at the intersection of crypto and AI. This Morning Minute ex...
Ford faces a turning point as it expands EV capabilities while navigating a volatile market. Here are three scenarios...
Oil volatility could create a rare buy-on-dip window for memory names. Jim Cramer says Western Digital and Micron may...
Unity Software’s latest guidance sparked a sharp rally, underscoring how Vector AI could redefine monetization in int...
A half-century-old rule for scaling software teams is breaking as AI fueled capital changes how firms grow. Investors...
ASML sits at the core of modern chipmaking. This article examines whether asml stock undervalued semiconductor opport...
SpaceX has vaulted to a $2.8 trillion valuation, leaving investors debating whether the growth story justifies the pr...
Analysts stage a fresh look at Tesla’s 2027 price target, signaling a measured path ahead as product rollouts and cas...
AMD leads a chip stock rebound with a 7% jump, followed by Intel and Broadcom, as analysts frame the pullback as a bu...
Nvidia’s latest earnings release produced solid numbers, but traders say the real move will come from the March GTC. ...
The race to commercialize solid-state batteries is accelerating, and QuantumScape sits at the center. This deep dive ...